Evidence map›Paper›PMID 40976913›Full record

Observational studyJournal of paediatrics and child health2025

Marked Variation in Paediatric Problematic Severe Asthma Services Across Australia and New Zealand.

Ajay Kevat, Samuel Dalton, Bernadette Goddard, Laura Mitchell, Eloise Graham, Louisa Owens, Tom Goddard, Melinda Gray, Stuart Haggie, Ingrid Laing and 6 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of paediatrics and child health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ajay KevatDepartment of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.ORCID 0000-0001-9881-6478
Samuel DaltonDepartment of Paediatrics, Waitaha Canterbury, Health New Zealand Te Whatu Ora, New Zealand.
Bernadette GoddardPaediatric Respiratory Department, John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia.
Laura MitchellKids Cancer Centre, Sydney Children's Hospital Randwick, Sydney, Australia.
Eloise GrahamUniversity of Queensland Medical School, Brisbane, Australia.
Louisa OwensSchool of Clinical Medicine, University of New South Wales, Sydney, Australia.
Tom GoddardFaculty of Health and Medical Sciences, The University of Adelaide, Australia.
Melinda GrayDepartment of Respiratory Medicine, Sydney Children's Hospital, Sydney, Australia.
Stuart HaggieRespiratory and Sleep Medicine Department, The Children's Hospital at Westmead, Sydney, Australia.
Ingrid LaingSchools of Medicine and Biomedical Science, The University of Western Australia, Australia.
Anna MulhollandDepartment of Paediatrics, Starship Children's Health, New Zealand.
Stephen OoRespiratory and Sleep Department, Perth Children's Hospital, Perth, Western Australia, Australia.
Robert RosebyDepartment of Respiratory and Sleep Medicine, Monash Children's Hospital, Victoria, Australia.
Jagdev SinghRespiratory and Sleep Medicine Department, The Children's Hospital at Westmead, Sydney, Australia.
Shivanthan ShanhikumarRespiratory Diseases, Murdoch Children's Research Institute, Parkville, Victoria, Australia.ORCID 0000-0001-6000-3180
Paul D RobinsonDepartment of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Australia.

Funding

Novartis Australia
6 · The paper itself

Abstract

aimsAsthma affects > 10% of children in Australia and New Zealand (NZ), with up to 5% of those having severe disease, presenting a management challenge. We aimed to survey tertiary paediatric respiratory services across Australia and NZ using a custom-designed questionnaire, to conduct a cross-sectional observational study of the numbers of children with problematic severe asthma (PSA) seen, the number treated with biologic therapy, outpatient clinic/multidisciplinary team (MDT) services available, investigations and tools routinely used and approaches utilised for transition to adult care.

methodsA custom-designed online survey was distributed via email to Directors of public paediatric respiratory services across Australia and NZ (n = 14). Reminders to prompt completion were emailed regularly over 3 months.

resultsAll sites provided survey responses. The estimated number of children with PSA across 12 sites was 561 (53 prescribed biologic treatment); two sites felt unable to provide accurate estimations. Most sites (n = 8) did not have a MDT approach either as MDT clinics or meetings; patients were managed in either asthma (n = 7, 50%) or general respiratory clinics. Most sites (85%) utilised questionnaires regarding asthma control for assessment, although some utilised additional questionnaires. Remaining tools and investigations varied widely across centres. Only four sites (29%) had established processes for transition to adult care.

conclusionsGiven notable heterogeneity in service availability and PSA management across tertiary sites, children may experience variability in care dependent on their location. Most centres lack MDT models of care, which are considered the international best-practise standard for management of children with PSA.

Indexed as

AsthmaAdolescentAustraliaChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleNew ZealandSeverity of Illness IndexSurveys and QuestionnairesasthmaAustraliachildNew Zealand

Identifiers

PMID40976913
PMCPMC12689487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.